In light of growing evidence that motor challenges are common among people with autism, we asked five researchers how these problems fit into the definition of the condition.

This month’s newsletter highlights findings on the use of three medication types during pregnancy.

The in-depth approach shows mutations in the autism-linked gene disrupt neuronal growth and communication, as well as mitochondrial gene expression.

Psychiatric genomics promises to shed light on the genetic basis of autism, but it’s vital to include Africa in this research, Iyegbe and Okewole say.

The temporary easing of traits that a minority of autistic children are reported to show during or after a fever may stem from a rise in body temperature.

The competitive rower-turned-researcher spoke to Spectrum about how trying out for the U.S. national rowing team and a subsequent coaching position shaped her study of speech development.

A meeting in Texas reckons with the future of treatment, following two setbacks in 2020.

One drug blocks mTOR signaling, and the other stops the blocker from acting anywhere in the body but the brain, lowering the potential for side effects.

Parents’ health, treatment dosages and sensory perception feature in this month’s crop of null and replicated results.

Iama Therapeutics is hoping a new class of molecule will prove successful against an old target in autism.